Product image of Erlotinib Ratiopharm (Erlotinib) supplied by GNH India

Erlotinib Ratiopharm

Active Ingredient:
Erlotinib
Origin:
EU

Erlotinib Ratiopharm (Erlotinib)

Erlotinib Ratiopharm is an oral medication used to treat certain types of cancer. This targeted therapy works by inhibiting specific proteins involved in cancer cell growth.

Manufacturer / TM Owner

Ratiopharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Erlotinib Ratiopharm is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It is designed to target and inhibit the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' and the answer lies in its ability to interfere with the signaling pathways that promote cancer cell proliferation.

Side Effects

  • Common effects of Erlotinib Ratiopharm may include skin rash, diarrhea, and fatigue. Some users also report appetite loss and nausea. These effects can vary in intensity and duration, depending on individual factors.

Precautions & Warnings

  • Erlotinib Ratiopharm should be handled with care, as it is a potent medication. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this treatment.

Avoid Interactions

  • Erlotinib Ratiopharm may interact with other medications, including certain antibiotics and antifungals. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, smoking can reduce the effectiveness of Erlotinib.

Frequently Asked Questions

Erlotinib Ratiopharm is used to treat certain types of cancer, including non-small cell lung cancer and pancreatic cancer.

Erlotinib Ratiopharm is taken orally, typically once daily. The exact dosage and schedule should be determined by a healthcare professional.

Common side effects include skin rash, diarrhea, fatigue, appetite loss, and nausea.

Erlotinib Ratiopharm may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Erlotinib Ratiopharm may not be suitable for everyone, especially those with certain medical conditions or allergies. Always consult a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Erlotinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT